Logo Logo Logo Logo Logo
  • Home
  • About
    • About Atomo
    • Board of Directors
    • Executive Team
    • Governance
  • OEM Devices
    • Device Platforms
      • Elion RDT platform
      • Pascal RDT platform
      • Galileo RDT platform
      • Losev RDT platform
      • Newton RDT platform
      • Franklin RDT platform
    • OEM Service
      • Development Pathway
  • COVID-19
  • HIV
    • HIV Professional Use Test
    • HIV Self Testing
  • News
    • Press Releases
    • News
  • Investor Centre
  • Contact
    • Media Centre
  • Home
  • About
    • About Atomo
    • Board of Directors
    • Executive Team
    • Governance
  • OEM Devices
    • Device Platforms
      • Elion RDT platform
      • Pascal RDT platform
      • Galileo RDT platform
      • Losev RDT platform
      • Newton RDT platform
      • Franklin RDT platform
    • OEM Service
      • Development Pathway
  • COVID-19
  • HIV
    • HIV Professional Use Test
    • HIV Self Testing
  • News
    • Press Releases
    • News
  • Investor Centre
  • Contact
    • Media Centre

14 Jul AFR: Sector outperformance set to continue for a long time

Posted at 18:00h in News by Rebecca James 0 Comments
0 Likes

Atomo CEO, John Kelly talks about the need for a greater focus on converting healthcare research into commercial outcomes in this Australian Financial Review article.

 

Read the full article >

 

 

Tags:
Atomo Diagnostics, Australian Financial Review, John Kelly
Copyright 2020 Atomo Diagnostics
Privacy Policy
Australia (Head Office) Level 2, 701-703 Parramatta Road, Leichhardt, NSW 2040 Telephone: +61 (0)2 9099 4750